Trial intelligence / Profile preview

LSP-5415 Vaginal Ring Ovulation Inhibition Study

NCT05360550Phase 2Completed

Sponsor
Lupin Limited
Start
Jul 2022
Primary completion
Jan 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of ethinyl estradiol, etonogestrel in contraception, sponsored by Lupin Limited. Started Jul 2022; status: completed.

02

Drugs

ethinyl estradioletonogestrel
03

Conditions

contraception

Beyond the preview

Go deeper on NCT05360550.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05360550.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call